Diabetes Research and Clinical Practice
Volume 81, Issue 1 , Pages 61-67, July 2008

Knowledge after five-day teaching program in intensive insulin therapy performed at the onset of type 1 diabetes influence the development of late diabetic complications

Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Raszeja Hospital, Mickiewicza 2, 60-834 Poznan, Poland

Received 23 December 2007; accepted 13 February 2008. published online 31 March 2008.

Abstract 

We evaluated the influence of baseline diabetic knowledge on clinical course of type 1 diabetes treated with intensive functional insulin therapy (IFIT) from the onset of the disease. 86 subjects with newly diagnosed type 1 diabetes, aged 23.4±5.1 attended a five-day structured training program in IFIT at baseline, followed by a test consisting of 20 questions. Patients were divided into subgroups according to test results: group A>16, group B 12–16 and group C<12 scores. At follow-up (7.1±1.5 years) metabolic control and development of microangiopathy were assessed. Patients with low knowledge at baseline had higher HbA1c levels than subjects with higher knowledge (group C: 9.2±1.9 vs. group A: 7.7±1.5%, p<0.05 and vs. group B: 7.8±1.6%, p<0.05), higher BMI (group C: 23.9±3.2 vs. group A: 21.8±3.1kg/m2, p<0.05) and lower HDL-cholesterol level (group C: 1.8±0.5 vs. group A: 2.0±0.3mmol/l, p<0.05). Patients with retinopathy and albuminuria at follow-up had lower level of diabetic knowledge at baseline (respectively: 12.5±3.6 vs. 14.2±3.3 scores, p<0.05; and 12.6±2.9 vs. 14.1±3.5 scores, p<0.05). The development of microangiopathy was associated with lower diabetic knowledge (RR=3.71; 95%CI: 1.15–12.01, p=0.02 for retinopathy and RR=4.33; 95%CI: 0.98–19.10, p=0.04 for microalbuminuria). The higher diabetic knowledge at baseline the better metabolic control and lower risk of microangiopathy in the future.

Keywords: Intensive functional insulin therapy, Education, Type 1 diabetes, Retinopathy, Albuminuria

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(08)00092-2

doi:10.1016/j.diabres.2008.02.009

Diabetes Research and Clinical Practice
Volume 81, Issue 1 , Pages 61-67, July 2008